Can propranolol (beta-blocker) cause obsessive behavior?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol and Obsessive Behavior: No Direct Evidence

There is no documented evidence that propranolol causes obsessive-compulsive behavior or obsessions as defined by DSM-5 criteria. However, propranolol can cause psychiatric side effects including psychosis, mania, depression, and sleep disturbances that should be distinguished from true obsessive-compulsive disorder 1, 2, 3, 4.

Documented Psychiatric Side Effects of Propranolol

The established psychiatric adverse effects of propranolol include:

  • Mood disturbances: Depression and mood impairments have been documented in adults taking propranolol, though the mechanism involves effects on memory and psychomotor function rather than obsessive thinking 1.

  • Sleep-related problems: Sleep disturbances occur in 2-18.5% of patients, including agitation during the night, nightmares, and night terrors—these may be misinterpreted as obsessive rumination but are distinct phenomena 1.

  • Psychotic symptoms: Case reports document propranolol-induced hallucinations, paranoid ideations, and severe personality changes that resolved upon drug discontinuation 2, 4.

  • Manic symptoms: Propranolol can paradoxically induce manic episodes even at low doses (10 mg), with symptoms including agitation and behavioral changes 3.

Distinguishing True OCD from Propranolol Side Effects

According to DSM-5 criteria, obsessive-compulsive disorder requires specific features that are not reported with propranolol use 5:

  • Recurrent intrusive thoughts, urges, or impulses that the patient attempts to neutralize through compulsions
  • Time-consuming behaviors (>1 hour per day) aimed at reducing anxiety
  • The disturbance must NOT be attributable to the physiological effects of a medication 5

If a patient on propranolol develops what appears to be obsessive behavior, consider alternative explanations:

  • Agitation or restlessness from sleep disturbances rather than true obsessions 1
  • Psychotic symptoms with repetitive behaviors (which would be delusional, not obsessive) 2, 4
  • Manic symptoms with goal-directed hyperactivity (distinct from compulsions) 3
  • Pre-existing anxiety disorder being unmasked or worsened

Clinical Management Algorithm

If behavioral changes emerge on propranolol:

  1. Assess the specific symptoms: Determine whether the behavior meets criteria for obsessions/compulsions versus other psychiatric phenomena 5.

  2. Consider drug discontinuation: Most propranolol-induced psychiatric symptoms resolve rapidly after stopping the medication 2, 4.

  3. Switch to cardioselective beta-blocker if needed: Atenolol or metoprolol may avoid CNS effects since they are less lipophilic and cross the blood-brain barrier less readily 2.

  4. Avoid abrupt discontinuation: Taper propranolol to prevent rebound symptoms, particularly in patients using it regularly 1, 6.

Important Caveats

  • The evidence base consists primarily of case reports for psychiatric side effects, making it difficult to establish causation definitively 2, 3, 4.

  • Interestingly, propranolol has been used therapeutically to treat agitation and aggressive behavior in dementia at low doses (10-80 mg/day), suggesting its behavioral effects are complex and dose-dependent 7.

  • No evidence suggests propranolol causes the specific syndrome of obsessive-compulsive disorder as defined by modern diagnostic criteria 5.

References

Guideline

Propranolol and Depression: Mechanism and Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Propranolol-induced psychosis.

Drug intelligence & clinical pharmacy, 1984

Research

Psychosis with propranolol: still not recognized?

Postgraduate medical journal, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Propranolol for Stage Fright

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.